Neuland Laboratories Ltd
NSE:NEULANDLAB

Watchlist Manager
Neuland Laboratories Ltd Logo
Neuland Laboratories Ltd
NSE:NEULANDLAB
Watchlist
Price: 14 904.95 INR 0.93% Market Closed
Market Cap: 191.2B INR
Have any thoughts about
Neuland Laboratories Ltd?
Write Note

Neuland Laboratories Ltd
Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Neuland Laboratories Ltd
Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Neuland Laboratories Ltd
NSE:NEULANDLAB
Common Stock
â‚ą129m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Common Stock
â‚ą834m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Common Stock
â‚ą1.6B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Common Stock
â‚ą2.4B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Common Stock
â‚ą1.7B
CAGR 3-Years
26%
CAGR 5-Years
15%
CAGR 10-Years
7%
M
Mankind Pharma Ltd
NSE:MANKIND
Common Stock
â‚ą400.6m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Neuland Laboratories Ltd
Glance View

Market Cap
191.2B INR
Industry
Pharmaceuticals

Neuland Laboratories Ltd. manufactures and exports bulk pharmaceutical ingredients and intermediates for the generics industry. The company is headquartered in Hyderabad, Telangana and currently employs 1,521 full-time employees. The firm is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. The firm operates through manufacture of active pharmaceutical ingredients and allied services. The firm has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Its products and services include Levetiracetam, Mirtazapine, Ciprofloxacin, Enalapril, Sotalol, Labetalol and Custom Manufacturing Services. The Company’s capabilities include FBRM, research and development, peptide laboratory, poly block reactors, laboratory reactors, heating and cooling systems, hazardous and wet laboratory, PID Laboratory Unit-III, PID Laboratory B-S Unit-I, and other lab equipment. The firm has 3 manufacturing facilities and one R&D facility in Hyderabad.

NEULANDLAB Intrinsic Value
5 499.33 INR
Overvaluation 63%
Intrinsic Value
Price

See Also

What is Neuland Laboratories Ltd's Common Stock?
Common Stock
129m INR

Based on the financial report for Jun 30, 2024, Neuland Laboratories Ltd's Common Stock amounts to 129m INR.

What is Neuland Laboratories Ltd's Common Stock growth rate?
Common Stock CAGR 3Y
0%

Over the last year, the Common Stock growth was 0%.

Back to Top